These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25889091)

  • 21. Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus.
    Haidar A; Farid D; St-Yves A; Messier V; Chen V; Xing D; Brazeau AS; Duval C; Boulet B; Legault L; Rabasa-Lhoret R
    Diabetes Metab; 2014 Jun; 40(3):211-4. PubMed ID: 24656963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose turnover after replacement of usual therapy by insulin in insulin-naive type 2 diabetes subjects.
    Thabit H; Kumareswaran K; Haidar A; Leelarathna L; Caldwell K; Elleri D; Allen JM; Nodale M; Wilinska ME; Jackson NC; Umpleby AM; Evans ML; Hovorka R
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2225-32. PubMed ID: 24606105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Glucagon Action in Patients With Type 1 Diabetes.
    Emami A; Youssef JE; Rabasa-Lhoret R; Pineau J; Castle JR; Haidar A
    IEEE J Biomed Health Inform; 2017 Jul; 21(4):1163-1171. PubMed ID: 27448377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GoCARB in the Context of an Artificial Pancreas.
    Agianniotis A; Anthimopoulos M; Daskalaki E; Drapela A; Stettler C; Diem P; Mougiakakou S
    J Diabetes Sci Technol; 2015 May; 9(3):549-55. PubMed ID: 25904142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Diabet Med; 2010 Apr; 27(4):480-4. PubMed ID: 20536523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans.
    Juhl CB; Gjedsted J; Nielsen MF; Schmitz O
    Metabolism; 2012 Aug; 61(8):1177-81. PubMed ID: 22386942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
    Davis T; Salahi A; Welsh JB; Bailey TS
    Diabetes Obes Metab; 2015 Dec; 17(12):1126-32. PubMed ID: 26179879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensor-Augmented Pump-Based Customized Mathematical Model for Type 1 Diabetes.
    Grosman B; Wu D; Miller D; Lintereur L; Roy A; Parikh N; Kaufman FR
    Diabetes Technol Ther; 2018 Mar; 20(3):207-221. PubMed ID: 29565722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.